12-111598992-GC-G

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 4P and 5B. PVS1_StrongBP6BS2

The NM_001372574.1(ATXN2):​c.42delG​(p.Gln14HisfsTer32) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00266 in 1,220,360 control chromosomes in the GnomAD database, including 8 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars). Synonymous variant affecting the same amino acid position (i.e. Q14Q) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0016 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0028 ( 6 hom. )

Consequence

ATXN2
NM_001372574.1 frameshift

Scores

Not classified

Clinical Significance

Likely benign no assertion criteria provided B:1O:1

Conservation

PhyloP100: 0.00500

Publications

2 publications found
Variant links:
Genes affected
ATXN2 (HGNC:10555): (ataxin 2) This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
ATXN2-AS (HGNC:51838): (ATXN2 antisense RNA)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 4 pathogenic variants in the truncated region.
BP6
Variant 12-111598992-GC-G is Benign according to our data. Variant chr12-111598992-GC-G is described in ClinVar as Likely_benign. ClinVar VariationId is 3055440.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 228 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001372574.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN2
NM_001372574.1
MANE Select
c.42delGp.Gln14HisfsTer32
frameshift
Exon 1 of 25NP_001359503.1A0A5F9ZI57
ATXN2
NM_002973.4
c.42delGp.Gln14HisfsTer32
frameshift
Exon 1 of 25NP_002964.4V9GY86
ATXN2
NM_001310121.1
c.-65+582delG
intron
N/ANP_001297050.1Q2M2R5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN2
ENST00000673436.1
MANE Select
c.42delGp.Gln14HisfsTer32
frameshift
Exon 1 of 25ENSP00000500925.1A0A5F9ZI57
ATXN2
ENST00000550104.5
TSL:1
c.522delGp.Gln174HisfsTer32
frameshift
Exon 1 of 25ENSP00000446576.2Q99700-1
ATXN2
ENST00000608853.5
TSL:1
c.42delGp.Gln14HisfsTer32
frameshift
Exon 1 of 25ENSP00000476504.1V9GY86

Frequencies

GnomAD3 genomes
AF:
0.00161
AC:
227
AN:
141320
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00465
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00156
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000198
Gnomad SAS
AF:
0.00167
Gnomad FIN
AF:
0.000975
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000433
Gnomad OTH
AF:
0.00152
GnomAD2 exomes
AF:
0.00214
AC:
206
AN:
96454
AF XY:
0.00220
show subpopulations
Gnomad AFR exome
AF:
0.00173
Gnomad AMR exome
AF:
0.00146
Gnomad ASJ exome
AF:
0.00249
Gnomad EAS exome
AF:
0.00252
Gnomad FIN exome
AF:
0.00432
Gnomad NFE exome
AF:
0.00175
Gnomad OTH exome
AF:
0.00270
GnomAD4 exome
AF:
0.00280
AC:
3018
AN:
1078972
Hom.:
6
Cov.:
71
AF XY:
0.00284
AC XY:
1502
AN XY:
529110
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00689
AC:
148
AN:
21474
American (AMR)
AF:
0.00721
AC:
190
AN:
26368
Ashkenazi Jewish (ASJ)
AF:
0.00465
AC:
80
AN:
17218
East Asian (EAS)
AF:
0.00457
AC:
114
AN:
24962
South Asian (SAS)
AF:
0.00606
AC:
347
AN:
57244
European-Finnish (FIN)
AF:
0.00518
AC:
147
AN:
28398
Middle Eastern (MID)
AF:
0.00558
AC:
19
AN:
3406
European-Non Finnish (NFE)
AF:
0.00209
AC:
1785
AN:
855284
Other (OTH)
AF:
0.00421
AC:
188
AN:
44618
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.306
Heterozygous variant carriers
0
336
673
1009
1346
1682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00161
AC:
228
AN:
141388
Hom.:
2
Cov.:
31
AF XY:
0.00156
AC XY:
108
AN XY:
69328
show subpopulations
African (AFR)
AF:
0.00467
AC:
154
AN:
32980
American (AMR)
AF:
0.00156
AC:
23
AN:
14778
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3442
East Asian (EAS)
AF:
0.000198
AC:
1
AN:
5042
South Asian (SAS)
AF:
0.00167
AC:
8
AN:
4786
European-Finnish (FIN)
AF:
0.000975
AC:
10
AN:
10256
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.000433
AC:
29
AN:
66904
Other (OTH)
AF:
0.00150
AC:
3
AN:
2002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
ATXN2-related disorder (1)
-
-
-
Parkinson disease, late-onset (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.0050
Mutation Taster
=168/32
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs780952627; hg19: chr12-112036796; COSMIC: COSV108225762; COSMIC: COSV108225762; API